ATE338065T1 - Zelluläre aufnahme des stiels des rezeptors für polymere immunglobuline (pigr) und damit zusammenhängende liganden - Google Patents

Zelluläre aufnahme des stiels des rezeptors für polymere immunglobuline (pigr) und damit zusammenhängende liganden

Info

Publication number
ATE338065T1
ATE338065T1 AT97925515T AT97925515T ATE338065T1 AT E338065 T1 ATE338065 T1 AT E338065T1 AT 97925515 T AT97925515 T AT 97925515T AT 97925515 T AT97925515 T AT 97925515T AT E338065 T1 ATE338065 T1 AT E338065T1
Authority
AT
Austria
Prior art keywords
stalk
receptor
pigr
polymeric immunoglobulin
associated ligands
Prior art date
Application number
AT97925515T
Other languages
English (en)
Inventor
Keith E Mostov
Janice Richman-Eisenstat
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE338065T1 publication Critical patent/ATE338065T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4712—Cystic fibrosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6056—Antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Holo Graphy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97925515T 1996-06-04 1997-05-14 Zelluläre aufnahme des stiels des rezeptors für polymere immunglobuline (pigr) und damit zusammenhängende liganden ATE338065T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1895896P 1996-06-04 1996-06-04

Publications (1)

Publication Number Publication Date
ATE338065T1 true ATE338065T1 (de) 2006-09-15

Family

ID=21790632

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97925515T ATE338065T1 (de) 1996-06-04 1997-05-14 Zelluläre aufnahme des stiels des rezeptors für polymere immunglobuline (pigr) und damit zusammenhängende liganden

Country Status (11)

Country Link
US (2) US6042833A (de)
EP (1) EP0934338B1 (de)
JP (1) JP2000511432A (de)
CN (1) CN1221428A (de)
AT (1) ATE338065T1 (de)
AU (1) AU728587B2 (de)
CA (1) CA2256304A1 (de)
DE (1) DE69736602D1 (de)
IL (1) IL127238A (de)
RU (1) RU2191781C2 (de)
WO (1) WO1997046588A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU749032B2 (en) * 1997-06-13 2002-06-20 Johns Hopkins University, The Therapeutic nanospheres
AU769259B2 (en) * 1999-02-12 2004-01-22 Board Of Regents, The University Of Texas System Polymeric immunoglobulin receptor (pIgR)-binding domains and methods of use therefor
WO2001049710A2 (de) * 1999-12-30 2001-07-12 Frank Hans Georg Verfahren zur identifizierung von substanzen, die säugetier-epitope nachahmen
MXPA02009449A (es) * 2000-03-27 2003-09-22 Univ California Ligandos dirigidos a la region no del eje del componente no secretor de la pigr y metodos de uso de los mismos.
US20020136732A1 (en) * 2000-04-23 2002-09-26 Houston L. L. Compositions comprising carriers and transportable complexes
US6924412B1 (en) * 2000-07-21 2005-08-02 Arriwan Holding B.V. Means and methods for raising antibody concentration in compartments of the body of a non-human animal
JP2005500002A (ja) * 2000-10-02 2005-01-06 エリゼク・ファーマシュウティカルズ・インコーポレイテッド 生物学的に活性な薬剤を細胞関門を越えて輸送するための組成物および方法
US20030166160A1 (en) * 2001-09-06 2003-09-04 Hawley Stephen B. Compounds and molecular complexes comprising multiple binding regions directed to transcytotic ligands
US20040219542A1 (en) * 2001-02-02 2004-11-04 L.L. Houston Compositions and methods for identifying, characterizing, optimizing and using ligands to transcytotic molecules
EP1587524A4 (de) * 2003-01-09 2006-07-26 Arizeke Pharmaceuticals Inc Zusammensetzungen und verfahren für die gezielte biologische abgabe von molekularen trägern
RU2382052C1 (ru) * 2008-07-09 2010-02-20 Институт синтетических полимерных материалов (ИСПМ) им. Н.С. Ениколопова РАН Способ получения модифицированной токоферолом сшитой соли гиалуроновой кислоты и биоактивная композиция на ее основе
MX2022001278A (es) * 2019-08-02 2022-05-03 Janssen Biotech Inc Materiales y métodos para el direccionamiento al receptor de anticuerpos poliméricos.
CN116322776A (zh) 2020-08-03 2023-06-23 詹森生物科技公司 用于病毒治疗剂中的多向生物转运的材料和方法
CN114088939A (zh) * 2021-11-19 2022-02-25 中国人民解放军陆军军医大学第一附属医院 一种原发性胆汁性胆管炎诊断用分子标志物及其应用
CN116444612B (zh) * 2022-11-30 2024-07-16 内蒙古伊利实业集团股份有限公司 乳源活性肽apadpgrptgy及其制备方法与应用

Also Published As

Publication number Publication date
EP0934338A4 (de) 2002-05-29
CN1221428A (zh) 1999-06-30
DE69736602D1 (de) 2006-10-12
RU2191781C2 (ru) 2002-10-27
AU3063297A (en) 1998-01-05
WO1997046588A1 (en) 1997-12-11
AU728587B2 (en) 2001-01-11
JP2000511432A (ja) 2000-09-05
IL127238A (en) 2001-07-24
CA2256304A1 (en) 1997-12-11
US6340743B1 (en) 2002-01-22
US6042833A (en) 2000-03-28
IL127238A0 (en) 1999-09-22
EP0934338A1 (de) 1999-08-11
EP0934338B1 (de) 2006-08-30

Similar Documents

Publication Publication Date Title
ATE338065T1 (de) Zelluläre aufnahme des stiels des rezeptors für polymere immunglobuline (pigr) und damit zusammenhängende liganden
ATE168013T1 (de) Humanisierte chimäre anti-''icam-1'' antikörper, herstellungsverfahren und verwendung
PT724456E (pt) Anticorpos contra cd4
ATE248605T1 (de) Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
EP1775307A3 (de) Bispezifischer Antikörper zur effektiven Behandlung von B-Zell Lymphomen und Zellinien
DE69221147D1 (de) Nicht glycosylierter Anti-CD3-IgG-Antikörper
GEP20105118B (en) Anti-vegf antibodies
DE69535133D1 (de) Humanisierte antikörper gegen das leukozytenadhäsionsmolekül vla-4
FI874047L (fi) Monoklonaalisia vasta-ainemolekyylejä, joilla on katalyyttisiä ominaisuuksia omaavia vasta-aineen sitovia kohtia
ATE171461T1 (de) Immunstimulierende monoklonale antikörper
WO2001016114A3 (en) Heterocyclic compounds and methods for modulating cxcr3 function
DK0667902T3 (da) CDR-graftede humaniserede, kimæriske T-celle-antistoffer
DE69939820D1 (de) Internalisierende erbb2 antikörper
GR1002306B (el) Αναλυση και διαταξη συγκολλησεως στηλης.
DE3577663D1 (de) Traegerkatalysator fuer hydrobehandlung, enthaltend molybdaen- und wolframsulfid, aktiviert durch mangansulfid und dessen verwendung.
EP0672253A4 (de) Monoklonale antikorper gegen das karzinom assoziierte antigen ski, verfahrenzu ihrer herstellung und ihre verwendung.
EP0816496A3 (de) Nierenkarzinom-spezifische-T-Zellen
DE3583296D1 (de) Oncofetal spezifische monoklonale antikoerper, deren herstellung und verwendung.
EP0588036A3 (de) Zusammensetzung zur Isolierung von Apaminrezeptoren, Apaminbindungsprotein und deren Verwendungen.
Baum CHARACTERIZATION AND MAPPING OF B LYMPHOCYTE FC RECEPTORS FOR IMMUNOGLOBULIN-G.
ATE341564T1 (de) Anti-idiotypische monoklonale antikörper, deren verwendung zur aktiven immuntherapie bösartiger tumoren, und zusammensetzungen die diese enthalten
ES1001777U (es) Estructura laminar perfeccionada para invernaderos y similares
IT219301Z2 (it) Calendario per agende, diari e simili.
TR199600671A2 (tr) Kronik lenfositik lösemi'ye spesifik monoklonal antikor ve bunu üreten hücre.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties